WallStreetZenWallStreetZen
Analyst Ranking
Top 1%
#41 out of 4053 analysts
Average Return
+66.09%
Win Rate
61%17 out of 28
Risk vs Reward
Poor
Good

Andrew D'Silva's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Optimizerx CorpOPRX
+468.59%$8.50$48.33
2020-04-06 -
2021-04-07
Strong Buy
Cormedix IncCRMD
+308.09%$2.35$9.59
2020-03-17 -
2021-03-18
Strong Buy
Edap Tms SaEDAP
+305.83%$2.23$9.05
2020-04-14 -
2021-04-15
Strong Buy
Cryoport IncCYRX
+212.88%$16.38$51.25
2020-04-06 -
2021-04-07
Strong Buy
Verso CorpVRS
+201.98%$6.07$18.33
2017-04-27 -
2018-04-27
Strong Buy

Andrew D'Silva's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Ontrak IncOTRK
1Hold$15.00N/ADowngrades
a year ago
Multiplan CorpMPLN
1Strong Buy$10.00N/AInitiates Coverage On
2 years ago
Cryoport IncCYRX
2Strong Buy$81.00N/AMaintains
2 years ago
Viewray IncVRAY
3Strong BuyN/AN/AUpgrades
2 years ago
Edap Tms SaEDAP
1Strong Buy$5.50N/AInitiates Coverage On
2 years ago
Optimizerx CorpOPRX
1Strong Buy$18.00N/AMaintains
3 years ago
Intricon CorpIIN
6Strong Buy$26.50N/AMaintains
3 years ago
Harrow Health IncHROW
2Strong Buy$10.00N/AMaintains
3 years ago
Alimera Sciences IncALIM
1Strong Buy$15.00N/AMaintains
3 years ago
Eyepoint Pharmaceuticals IncEYPT
1Hold$1.00N/ADowngrades
3 years ago
Cormedix IncCRMD
2Strong Buy$10.00N/AMaintains
3 years ago
Geron CorpGERN
1Strong Buy$3.50N/AMaintains
3 years ago
Verso CorpVRS
4Hold$26.00N/ADowngrades
3 years ago
Unique Fabricating IncUFAB
2Strong Buy$9.00N/AMaintains
4 years ago
Adamis Pharmaceuticals CorpADMP
1Hold$2.50N/ADowngrades
4 years ago
Osi Systems IncOSIS
2Strong Buy$92.50N/AMaintains
4 years ago
Cumberland Pharmaceuticals IncCPIX
1Strong Buy$8.75N/AMaintains
4 years ago
Oramed Pharmaceuticals IncORMP
1Strong Buy$20.00N/AReinstates
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.